COST-EFFECTIVENESS OF ANTI-BCMA CAR T-CELL THERAPY IN TRIPLE-CLASS REFRACTORY MULTIPLE MYELOMA

被引：0
|
作者：
Barnes, J., I [1 ]
Frosch, Z. A. [2 ]
Garfall, A. L. [3 ]
Vogl, D. [3 ]
Lin, J. [3 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[3] Univ Penn, Philadelphia, PA 19104 USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE41
引用
收藏
页码：S343 / S343
页数：1
相关论文
共 50 条
  • [21] An Anti-Bcma CAR T-Cell Therapy (C-CAR088) Shows Promising Safety and Efficacy Profile in Relapsed or Refractory Multiple Myeloma
    An, Gang
    Sui, Weiwei
    Wang, Tingyu
    Qu, Xiaoyan
    Zhang, Xian
    Yang, Junfang
    Zhang, Yan
    Zhang, Lu
    Zhu, Judy
    Zheng, Chengxiao
    Yan, Xiuxiu
    Lv, Xiaoteng
    Lan, Liping
    Yang, Dingzhu
    Huo, Ningning
    Han, Ting
    Zhao, Dijun
    Qin, Shichao
    Wu, Junfeng
    Yao, Xin
    Zhu, Shigui
    Ren, Jiaqiang
    Zhang, Li
    Huang, Jiaqi
    Humphries, Michael
    Yao, Yihong
    Zhou, Daobin
    Li, Jianyong
    Lu, Peihua
    BLOOD, 2020, 136
  • [22] Anti-BCMA CAR-T Cell Therapy in Relapsed or Refractory Multiple Myeloma Patients with Impaired Renal Function
    He, Shao-long
    Cheng, Yu-hang
    Wang, Di
    Xu, Meng-lei
    Que, Yi-mei
    Xu, Yan-jie
    Ma, Liang-ming
    Li, Chun-rui
    Zhou, Jian-feng
    CURRENT MEDICAL SCIENCE, 2021, 41 (03) : 474 - 481
  • [23] Developing a Novel Anti-Bcma CAR-T for Relapsed or Refractory Multiple Myeloma
    Yao, Xin
    Zhu, Shigui
    Huang, Jiaqi
    Qu, Xiaoyan
    Zhu, Judy
    Wei, Yutian
    Lan, Liping
    Lv, Xiaoteng
    Wu, Junfeng
    Wang, Rirfei
    Yang, Dingzhu
    Zheng, Chengxiao
    Zhao, DiJun
    Fan, Lei
    Huang, Fei
    Lu, Hua
    Zhang, Chaocan
    Chen, Cheng
    Li, Yanfeng
    Ren, Jiaqiang
    Zhang, Li
    Humphries, Michael
    Li, Jianyong
    Yao, Yihong
    BLOOD, 2019, 134
  • [24] Phase 1 study of C-CAR088, a novel humanized anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma
    Qu, Xiaoyan
    An, Gang
    Sui, Weiwei
    Wang, Tingyu
    Zhang, Xian
    Yang, Junfang
    Zhang, Yan
    Zhang, Lu
    Zhu, Dan
    Huang, Jiaqi
    Zhu, Shigui
    Yao, Xin
    Li, Jing
    Zheng, Chengxiao
    Zhu, Kevin
    Wei, Yutian
    Lv, Xiaoteng
    Lan, Liping
    Yao, Yihong
    Zhou, Daobin
    Lu, Peihua
    Qiu, Lugui
    Li, Jianyong
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (09)
  • [25] Anti-BCMA CAR-T Cell Therapy in Relapsed or Refractory Multiple Myeloma Patients with Impaired Renal Function
    Shao-long He
    Yu-hang Cheng
    Di Wang
    Meng-lei Xu
    Yi-mei Que
    Yan-jie Xu
    Liang-ming Ma
    Chun-rui Li
    Jian-feng Zhou
    Current Medical Science, 2021, 41 : 474 - 481
  • [26] A phase I study of anti-BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia
    Li, Chunrui
    Cao, Wenyue
    Que, Yimei
    Wang, Qiuxiang
    Xiao, Yi
    Gu, Chaojiang
    Wang, Di
    Wang, Jue
    Jiang, Lijun
    Xu, Hao
    Xu, Jinhuan
    Zhou, Xiaoxi
    Hong, Zhenya
    Wang, Na
    Huang, Liang
    Zhang, Shangkun
    Chen, Liting
    Mao, Xia
    Xiao, Min
    Zhang, Wei
    Meng, Li
    Cao, Yang
    Zhang, Tongcun
    Li, Jian
    Zhou, Jianfeng
    CLINICAL AND TRANSLATIONAL MEDICINE, 2021, 11 (03):
  • [27] Incidence of Parkinsonism As a Complication of Anti-BCMA CAR-T Cell Therapy in Multiple Myeloma
    Singh, Vaishnavi
    Master, Samip
    BLOOD, 2023, 142
  • [28] Increased Bone Turnover and Decreased BCMA Levels in Patients with Response to Anti-BCMA CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma
    Ussmann, Jule
    Fischer, Luise
    Born, Patrick
    Grieb, Nora
    Hoffmann, Sandra
    Baber, Ronny
    Wang, Song-Yau
    Kloetzer, Christina
    Heyn, Simone
    Herling, Marco
    Herling, Carmen
    Jentzsch, Madlen
    Franke, Georg-Nikolaus
    Hofbauer, Lorenz
    Platzbecker, Uwe
    Vucinic, Vladan
    Weidner, Heike
    Merz, Maximilian
    BLOOD, 2023, 142
  • [29] Anti-BCMA CAR T-Cell Therapy in a Patient with Refractory Anti-SRP Necrotizing Myopathy
    Qin, Chuan
    Dong, Ming-Hao
    Zhou, Luo-Qi
    Wang, Wen
    Song-Bai
    Li, Chun-Rui
    Wang, Di
    Zhang, Min
    Bu, Bi-Tao
    Tian, Dai-Shi
    Wang, Wei
    ANNALS OF NEUROLOGY, 2024, 96 : S99 - S100
  • [30] Hematopoietic reconstitution and infections after anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma are associated with pre-CAR-T bridging therapies
    Frenking, Jan
    Kauer, Joseph
    Hajiyianni, Marina
    Mai, Elias
    Michel, Christian
    Sester, Lilli
    John, Lukas
    Mueller-Tidow, Carsten
    Goldschmidt, Hartmut
    Weinhold, Niels
    Schmitt, Anita
    Schmitt, Michael
    Dreger, Peter
    Sauer, Sandra
    Raab, Marc
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S38 - S39
12345